Abstract:Objective To study the changes in levels of interleukin (IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α), and alkaline phosphatase (ALP) in the gingival crevicular fluid (GCF) of patients with severe chronic periodontitis before and after nonsurgical periodontal therapy and to explore the relationship among the levels of these four biomarkers in GCF, their periodontal status and their clinical significance to evaluate the effect of nonsurgical periodontal therapy and periodontitis activity. Methods In total, 30 patients with severe chronic periodontitis were enrolled in a 1-year longitudinal pilot study (Chinese Clinical Trial Registry: ChiCTR-OCH-13004679). At baseline and 1, 3, 6, and 12 months after nonsurgical therapy, the periodontal clinical indicators plaque index (PLI), probing depth (PD), clinical attachment loss (CAL), sulcus bleeding index (SBI) were recorded. Filter paper strips were used to collect two deep-pocket (probing depth ≥ 6 mm) and two shallow-pocket (probing depth ≤ 4 mm) periodontal sites for each patient and weighed. The levels of interleukin IL-6, IL-10, TNF-α, and ALP in GCF were assessed using enzyme-linked immunosorbent assay. Meanwhile, 30 healthy sites of 15 subjects with healthy periodontium were used as the baseline controls for patients with severe chronic periodontitis. Results At the baseline, the TNF-α, ALP and IL-6 levels in GCF of the disease sites of patients with periodontitis were significantly higher than those in healthy periodontal sites of the control group (P < 0.001), and the levels of IL-10 were significantly lower than those in the control group (P < 0.001). In patients with severe chronic periodontitis, the levels of TNF-α, ALP and IL-6 in GCF at deep-pocket sites were significantly higher than those at shallow-pocket sites (P <0.001), and the IL-10 levels were significantly lower than those at shallow-pocket sites (P < 0.001). 1, 3, 6, and 12 months after nonsurgical treatment, the levels of TNF-α and ALP in GCF at the shallow- and deep-pocket sites in patients with chronic periodontitis significantly decreased, the level of IL-10 significantly increased (P < 0.005), and the level of IL-6 in GCF at the deep-pocket sites significantly decreased (P < 0.005). However, there was no significant difference in IL-6 level at shallow-pocket sites (P > 0.05). 1, 3, 6, and 12 months after nonsurgical treatment, the periodontal clinical indicators were improved compared with the baseline. In addition, there was a significant correlation between the levels of these four biomarkers and the periodontal clinical parameters (P < 0.05). During the two follow-up visits after nonsurgical periodontal therapy, the sites with more than 2-mm increase in attachment loss had significant differences in the levels of the four biomarkers in the GCF compared with the previous visit time (P < 0.005). Conclusion The detection of the levels of these four biomarkers in GCF has strong clinical significance for assessing the severity of periodontitis and the efficacy of nonsurgical periodontal therapy. Increased levels of TNF-α, ALP, and IL-6 and decreased IL-10 levels in GCF may indicate periodontitis progression at this site.

Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D3 and Interleukin-1β in patients with aggressive periodontitis

Elevation of vitamin D-binding protein levels in the plasma of patients with generalized aggressive periodontitis.

1?,25-dihydroxyvitamin D3 promotes early osteogenic differentiation of PDLSCs and a 12-year follow-up case of early-onset vitamin D deficiency periodontitis

Effect of Initial Therapy on Gingival Crevicular Fluid MMP-8 Levels in Chronic Periodontitis and Aggressive Periodontitis

The long‐term effect of periodontitis treatment on changes in blood inflammatory markers in patients with generalized aggressive periodontitis

Elevated plasma calcifediol is associated with aggressive periodontitis.

Vitamin D-Binding Protein Levels in Plasma and Gingival Crevicular Fluid of Patients with Generalized Aggressive Periodontitis.

[Correlation Analysis Between Plasma Levels of 25-Hydroxy Vitamin D3 and Osteocalcin in Patients with Aggressive Periodontitis].

The Effect of Periodontal Initial Therapy on Chronic Periodontitis and Subgingival Periodontal Pathogen

Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis

Changes and clinical significance of four biomarkers in gingival crevicular fluid after nonsurgical periodontal therapy

[Levels of Interleukin-1Beta and Tumor Necrosis Factor-Alpha in Patients with Aggressive Periodontitis].

Human β-defensins are correlated with the immune infiltration and regulated by vitamin D3 in periodontitis

Preliminary investigation of the vitamin D pathway in periodontal connective tissue cells.

Systemic Inflammation Markers in Patients with Aggressive Periodontitis: a Pilot Study.

Periodontitis and Systemic Inflammation: Control of the Local Infection is Associated with a Reduction in Serum Inflammatory Markers.

Effect of Supplementation of Vitamin D in Patients with Periodontitis Evaluated before and after Nonsurgical Therapy

[Effect of Periodontal Initial Therapy on the Serum Level of Lipid in the Patients with Both Periodontitis and Hyperlipidemia].

Systemic inflammatory burden and local inflammation in periodontitis: What is the link between inflammatory biomarkers in serum and gingival crevicular fluid?

The gingival crevicular fluid levels of interleukin-11 and interleukin-17 in patients with aggressive periodontitis

Different doses of vitamin D supplementation to nonsurgical treatment for vitamin-D-insufficient patients with diabetic periodontitis and the effect on gingival BMP-2 levels